Bayer, the maker of Essure, announced on Friday that it will end its sales of the permanent birth control device in the United States by the end of 2018. The United States is the last country in which Essure is currently being sold. Bayer cited declining sales and demand as the driving force in its decision.
However, Essure has been surrounded by controversy in recent years, as thousands of women have said the device caused serious problems, such as perforations of the uterus and fallopian tubes and persistent pain, eventually requiring surgical removal. Additional problems cited by Essure users include migration of the coil into the pelvis and abdomen and unintended pregnancies.
In response to Bayer’s announcement, the FDA released a statement in which it noted its history with Essure, as well as its commitment to continue to monitor the device’s effect on the reported 750,000 patients worldwide who used Essure.
If you had an Essure device implanted and experienced any problems with the device, please contact Forester Haynie at the link below.SIGN UP NOW